Nebenwirkungen · Zaltrap
ZALTRAP 25 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 10
HOS-215772 · Präparat HOS-155534
System Organ Class Adverse Reaction Frequency Category All grades Grades ≥3 Infections and infestations Very common Infection (1) Infection (1) Common Neutropenic infection/sepsis (1) Neutropenic infection/sepsis (1) Urinary tract infection Nasopharyngitis Uncommon Urinary tract infection Blood and lymphatic system disorders Very common Leucopenia (2) Leucopenia (2) Neutropenia (1),(2) Neutropenia (2) Thrombocytopenia (2) Common Febrile neutropenia Febrile neutropenia Thrombocytopenia (2) Immune system disorders Common Hypersensitivity (1) Uncommon Hypersensitivity (1) Metabolism and nutrition disorders Very common Decreased appetite Weight loss Common Dehydration (1) Dehydration (1) Decreased appetite Weight loss Cardiac disorders Uncommon Cardiac failure
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-08-29T14:23:00Z · SHA-256 5b4c1b4848635140cdb6155c414b72c6acf77bc314124cac5763c972a8858b1a · Passage e3dc7820a218510996d0f6ae138eaeb001f618ec3fb207177c9e53bf9aa9add9 · Zeichen 2996–4598 im Abschnitt